The results will allow your doctor to make an informed decision about which drug is more likely to work for your type of cancer, based on the genetic mutations and other molecular characteristics ...
Researchers have discovered a three-drug combination that enhances the generation of CAR-T cells, a type of cancer immunotherapy, and could improve CAR-T cell production for clinical treatments.